Evidence map›Paper›PMID 28687727›Full record

ArticleScientific reports2017

Alpha 2 Na

Paula F Kinoshita, Lidia M Yshii, Ana Maria M Orellana, Amanda G Paixão, Andrea R Vasconcelos, Larissa de Sá Lima, Elisa M Kawamoto, Cristoforo Scavone

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Antiviral and immunomodulatory effects of ouabain against congenital Zika syndrome model.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. Article
  4. Sensational site: the sodium pump ouabain-binding site and its ligands.American journal of physiology. Cell physiology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Role of NaJournal of molecular medicine (Berlin, Germany) · 2022
    Review
  13. Astrocytic α2-NaScience translational medicine · 2022
    Article
  14. Endogenous Cardiac Steroids in Bipolar Disorder: State of the Art.International journal of molecular sciences · 2022
    Review
  15. NaAntioxidants (Basel, Switzerland) · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Role of endogenous ouabain in the etiology of bipolar disorder.International journal of bipolar disorders · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Paula F KinoshitaDepartment of Pharmacology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0002-9222-3556
Lidia M YshiiDepartment of Pharmacology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Ana Maria M OrellanaDepartment of Pharmacology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Amanda G PaixãoDepartment of Pharmacology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Andrea R VasconcelosDepartment of Pharmacology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Larissa de Sá LimaDepartment of Pharmacology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Elisa M KawamotoDepartment of Pharmacology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Cristoforo ScavoneDepartment of Pharmacology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil. criscavone@usp.br.
Universidade de São Paulo · BRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ouabain (OUA) is a cardiac glycoside that binds to Na

Indexed as

AnimalsCells, CulturedEnzyme InhibitorsGene SilencingInflammationLipopolysaccharidesMiceModels, BiologicalNeurogliaNeuroprotective AgentsOuabainSodium-Potassium-Exchanging ATPaseEnzyme InhibitorsLipopolysaccharidesNeuroprotective AgentsOuabainSodium-Potassium-Exchanging ATPase

Identifiers

PMID28687727
PMCPMC5501845
OpenAlexW2731328225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.